TABLE 3.

Antibiotic resistant genes and resistant phenotype of methicillin-resistant Staphylococcus aureus (MRSA) isolates in this study.

Antibiotics	Antibiotic resistant genes/No.	Resistant phenotype/Resistant rate
Beta-lactam	mecA/196, blaZ/132 ant(9)-Ia + aac(6′)-aph(2″)/59, ant9-Ia + aac(6′)-aph(2″) + aadD/30, ant(6)-Ia_aph(3″)-III/20, ant(9)-Ia/14, aadD + ant(9)-Ia/9, ant(9)-Ia + aac(3)-XI-aac(6′)-aph(2″) + aadD/1, ant(6)-Ia + aadD + aac(6)′-aph(2″)/1, aac(6′)-aph(2″)/2, aph(3″)-III/2, aph(2″)-I1/1, aadD/3, ant(9)-Ia + aac(6′)-aph(2′)/3,	OXA/100%, FOX/96.9%, CFZ/76.7%
Aminoglycoside	aadD + ant(9)-Ia/9aph(3′)-III + ant(6)-Ia + aac(6′)-aph(2″)/1	GEN 38.3%
	erm(A)/75, erm(C)/16, lnu(A)/3, erm(B)/16, erm(T)/1, lsa(E) + lnu(B) + erm(C)/1, lun(A) + erm(X) + erm(A)/1, erm(C) + lun(A)/2, lun(A) + erm(A)/26,
Macrolide	msr(A) + mph(C)/1	ERY/80.6%
	tet(M)/76, tet(K)/19, tet(L)/1,
Tetracycline	tet(M) + tet(K)/2	TET/55.9%, MIN/41.5%
Trimethoprim	dfrG/9	T/SUL/3.19%,
Fusidic acid	fusC/1, fusB/1	/
Fosfomycin	fosB4/2	/
Phenicol	cat(pC233)/3, fexA/1	/
/	/	RIP/2.12%, LNE/1.59%, DOX/28.7%, MXF/69.7%, TEC/0.53%
QAC	qacA/38, qacB/38	/